Patentability Of Anti Mould Concrete Curing Technologies.

🔹 1. Patentable Subject Matter for Concrete Technologies

Anti‑mould concrete curing technologies typically involve:

  • Chemical additives (e.g., biocides, antifungal agents)
  • Curing methods (e.g., humidity control, surface treatments)
  • Composite processes (combining curing and mould prevention)

These are usually processes or compositions of matter, which are generally patentable if they satisfy the standard criteria:

  1. Novelty
  2. Inventive step / Non‑obviousness
  3. Industrial applicability / Utility
  4. Enablement / Sufficient disclosure

🔹 2. Novelty / Anticipation Cases

Novelty means the invention is not already disclosed in prior art.

📌 In re Hall, C.C.P.A. 1977 (US)

Facts: Hall’s patent claims were rejected as anticipated. The court held that all elements of the claimed invention must be disclosed in a single prior art reference to destroy novelty.

Application:

  • For anti‑mould concrete curing, prior art describing general curing processes or mould inhibitors does not automatically anticipate a new chemical combination or process unless the exact combination is disclosed.

📌 Pfizer v. Apotex (Fed. Cir., 2009, US)

Key point: Even minor structural differences in compounds can confer novelty if prior art does not disclose them.

Application:

  • A new anti‑mould additive with a modified chemical structure or dosage could be novel over previously known mould inhibitors.

🔹 3. Non‑Obviousness / Inventive Step Cases

Non‑obviousness is often the main challenge in materials and construction technologies.

📌 KSR Int’l Co. v. Teleflex Inc. (US Supreme Court, 2007)

Key point: A claimed invention may be obvious if a person skilled in the art could combine known elements with predictable results.

Application:

  • Simply adding a known anti‑fungal chemical to a known concrete curing process may be obvious, unless it produces unexpected results such as significantly faster curing or superior mould prevention.

📌 Graham v. John Deere Co., 1966 (US Supreme Court)

Key point: Factors for non‑obviousness include prior art, differences from prior art, skill in the art, and secondary considerations (e.g., long-felt need, unexpected results).

Application:

  • If anti‑mould curing solves a long-standing problem in humid climates, and prior attempts failed, this strengthens inventive step arguments.

📌 Arylamide Fiber / Unexpected Results Analogy (Material Science Cases)

Principle: Demonstrating unexpected improvement in performance (e.g., concrete remains mould-free longer under high humidity) supports non-obviousness.

Application:

  • Tests comparing standard curing versus your method showing substantial reduction in mould formation can be critical.

🔹 4. Enablement / Written Description Cases

A patent must sufficiently describe how to carry out the invention.

📌 Ariad Pharmaceuticals v. Eli Lilly, 2010 (US Fed. Cir.)

Key point: A patent must provide a written description sufficient to show that the inventor possessed the invention.

Application:

  • The patent must explain:
    • Composition and concentration of anti-mould agents
    • Steps of the curing process
    • Environmental conditions (temperature, humidity)
    • Application techniques (spraying, mixing, coating)

Without detailed protocols, the patent may be invalidated.

🔹 5. Industrial Applicability / Utility Cases

The invention must be practically usable in industry.

📌 Diamond v. Chakrabarty, 1980 (US Supreme Court)

Key point: Human-made materials or processes with practical utility are patentable, even if biologically derived.

Application:

  • Anti-mould curing chemicals and processes used in real-world construction are clearly industrially applicable.

📌 Indian Patent Case: Ropan Therapeutics v. Lupin (Delhi High Court, 2019)

Principle: Mere aggregation of known substances without synergistic effect is not inventive.

Application:

  • A patent claim that simply adds known fungicides to curing water may not qualify.
  • Must demonstrate synergy, e.g., curing plus mould prevention produces concrete stronger or longer-lasting than either step alone.

🔹 6. European Patent Office Approach (Problem-Solution Method)

EPO requires:

  1. Identifying closest prior art
  2. Defining the technical problem solved
  3. Assessing obviousness of the solution

Example:

  • Closest prior art: standard concrete curing techniques
  • Technical problem: reducing mould formation during curing in humid climates
  • Solution: combination of curing method with specific anti-mould additive showing unexpected effectiveness
  • Outcome: potentially inventive if the effect is non-obvious and well-documented

🔹 7. Key Practical Considerations

FactorRelevance for Anti-Mould Concrete Patents
NoveltyMust not be disclosed in prior concrete curing or anti-fungal techniques
Inventive stepUnexpected results, synergy, or superior performance essential
Industrial applicationMust be usable in real-world construction settings
EnablementDetailed instructions, concentrations, and process parameters required
TestingComparative tests showing performance improvement strengthen patent claims

🔹 8. Summary

Anti-mould concrete curing technologies can be patentable if they meet the criteria:

  1. Novel composition or process (not found in prior art)
  2. Non-obvious combination of chemicals or curing techniques
  3. Industrial applicability with practical benefits
  4. Adequate disclosure to enable replication by skilled persons
  5. Supporting data showing unexpected improvement

Case Law Lessons:

  • Diamond v. Chakrabarty (1980) – practical, man-made inventions patentable
  • In re Hall (1977) – prior art must disclose all elements for anticipation
  • KSR v. Teleflex (2007) – obviousness assessed flexibly; predictable combinations may fail
  • Graham v. John Deere (1966) – secondary considerations matter
  • Ariad v. Eli Lilly (2010) – enablement and written description critical
  • Ropan v. Lupin (India, 2019) – synergy required for non-obviousness

LEAVE A COMMENT